FDA OKs First Oral Agent for Eosinophilic Esophagitis: Budesonide oral suspension is indicated for 12 weeks of treatment of EoE in adults and children as young ...
medscape.com/viewarticle/fda-oks-first-oral-agent-eosinophilic-esophagitis-2024a100031d
Paid articlePaid
Maryland scientists help expand use of drug that could revolutionize life for food allergy sufferers
wypr.org/wypr-news/2024-02-21/maryland-scientists-help-expand-use-of-drug-that-could-revolutionize-life-for-food-allergy-sufferers
Xolair for food allergies: How it works and what it costs: The FDA expanded approval for the asthma drug Xolair for multiple food allergies including peanuts and ...
nbcnews.com/health/health-news/xolair-food-allergies-works-costs-rcna140223
FDA OKs First CAR T-cell Trial for Children With Lupus: The trial is expected to begin this summer and will enroll 12 individuals under age 18 years.
medscape.com/viewarticle/fda-oks-first-car-t-cell-trial-children-lupus-2024a10006t6
FDA Expands Dupilumab for EoE to Younger Children: Dupilumab is now indicated for the treatment of eosinophilic esophagitis in children as young as 1 year and ...
medscape.com/viewarticle/fda-expands-dupilumab-eoe-younger-children-2024a10001v6
FDA Approves Drug to Reduce Accidental Food Allergies: The new indication makes Xolair (omalizumab) the first drug approved to mitigate allergic reactions to ...
medscape.com/viewarticle/fda-approves-drug-reduce-accidental-food-allergies-2024a10003b3
Paid articlePaid
FDA OKs First Interchangeable, High-Concentration Humira Biosimilar: It is the tenth adalimumab biosimilar approved by the regulatory agency.
medscape.com/viewarticle/fda-oks-first-interchangeable-high-concentration-humira-2024a10003rd
Paid articlePaid
New FDA-approved drug makes severe food allergies less life-threatening: Injections over several months allowed people to tolerate larger doses of trigger foods.
arstechnica.com/science/2024/02/fda-approves-first-drug-to-lessen-food-allergies-before-accidental-eating/
FDA OKs Subcutaneous Therapy for CIDP: HyQvia, which combines immunoglobulin with hyaluronidase, is administered subcutaneously by a healthcare professional or ...
ms.spr.ly/6183iSO4J
FDA Approves First Drug That Can Reduce Allergic Reaction After Exposure to Food Allergens
healthline.com/health-news/fda-approves-first-drug-that-can-reduce-allergic-reaction-after-exposure-to-food-allergens
Asthma drug omalizumab may offer a safety net for those with multiple food allergies: study
abc.net.au/news/health/2024-02-28/omalizumab-reduces-allergic-reactions-to-nuts-milk-wheat/103515400
IV Secukinumab Trials Hit Primary Endpoints in PsA, AxSpA: Two phase 3 trials of the recently approved IV formulation of secukinumab showed its efficacy vs ...
medscape.com/viewarticle/998678
FDA approves a drug to treat severe food allergies, including milk, eggs and nuts
npr.org/2024/02/18/1232304606/fda-approval-food-allergies-xolair
FDA Warns of Potentially Lethal Reaction to Seizure Meds: Levetiracetam and clobazam can cause a rare but serious drug reaction with eosinophilia and systemic ...
medscape.com/viewarticle/998860
FDA approves first drug to prevent severe food allergy reactions: Xolair, an injection for food allergy, is now available to adults and children 1 year and older ...
usatoday.com/story/news/health/2024/02/16/fda-food-allergies-treatment-xolair/72632879007/
US FDA approves Pfizer's inflammatory bowel disease drug: The U.S. Food and Drug Administration has approved Pfizer's (PFE.N) drug to treat adults with an ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-pfizers-inflammatory-bowel-disease-drug-2023-10-13/
Popular OTC medicines for colds and allergies don’t work, FDA panel says: Phenylephrine, a popular ingredient in many over-the-counter allergy and cold medicines ...
cnn.com/2023/09/12/health/phenylephrine-tablets-ineffective-fda-panel-says/
Recalled alligators were mislabeled dangerously as chocolate-covered cherries: The back label is for Chocolate Covered Cherries. Almonds aren’t on the ...
miamiherald.com/news/recalls/article287340185.html
US FDA approves Pfizer's hair loss drug: The U.S. Food and Drug Administration has approved Pfizer Inc's (PFE.N) drug to treat hair loss caused by an autoimmune ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-pfizers-hair-loss-drug-2023-06-23/
Quick Glance: Pfizer's Hair Loss Drug Receives FDA Approval
- The U.S. Food and Drug Administration has approved Pfizer Inc's medication for treating hair loss caused by an autoimmune disease.
- The medication, called Litfulo, has been approved for individuals aged 12 and up who suffer from severe alopecia areata.
- It is the second treatment of its kind to receive FDA approval, following Eli Lilly's Olumiant.
- The approval was based on data from a study that showed 80% or more hair coverage after six months of using the medication, compared to a placebo.
Stanford-led study offers relief to children with dangerous food allergies, leading to FDA drug approval
mercurynews.com/2024/02/25/stanford-led-study-offers-relief-to-children-with-dangerous-food-allergies-leading-to-fda-drug-approval/
Drug dramatically reduces kids’ life-threatening reactions to food allergen traces
thehill.com/policy/healthcare/4489857-drug-dramatically-reduces-kids-life-threatening-reactions-to-food-allergen-traces/
Asthma drug sharply cuts danger from food allergens: US study: A drug long used to treat asthma can help protect people from dangerous -- even fatal -- food ...
thedailystar.net/news/world/news/asthma-drug-sharply-cuts-danger-food-allergens-us-study-3552626
New medication offers hope for managing food allergies: Omalizumab is a new drug that the FDA recently approved to help treat food allergies ...
thedailystar.net/health/news/new-medication-offers-hope-managing-food-allergies-3563096
Did you know about 6% of the U.S. population has a food allergy, according to the CDC? The FDA has approved two first-of-its-kind treatments — one for severe ... Show more
FDA expands use of asthma drug Xolair to treat severe food allergies
FDA announces approval for first severe frostbite treatment
FDA expands use of asthma drug Xolair to treat severe food allergies
FDA announces approval for first severe frostbite treatment
Cake Recall as Dire Warning Issued: The cake slices were incorrectly labeled, meaning that the soy allergen was not appropriately listed.
newsweek.com/cake-recall-soy-allergy-1876325
Chocolate Recalled Over Fears of 'Life-Threatening' Allergy: "The recall was initiated after a consumer reported the issue to the retailer where they had ...
newsweek.com/chocolate-recalled-over-fears-life-threatening-allergy-1874835
FDA Approves First Medication For Treating Allergic Reactions To Multiple Foods: The injectable drug is not approved for “immediate emergency treatment of ...
forbes.com/sites/caileygleeson/2024/02/16/fda-approves-first-medication-for-treating-allergic-reactions-to-multiple-foods/
Thousands of Sandwiches Recalled Over Life-Threatening Allergy Fears: Nearly 4,000 sandwiches have been recalled after a cross-contamination incident.
newsweek.com/sandwich-recall-allergy-sesame-cross-contamination-fda-1870513
RA drug may help stop disease progression in people at higher risk: Researchers say that abatacept, a drug sold under the brand name Orencia that is used to ...
medicalnewstoday.com/articles/ra-drug-may-help-stop-disease-progression-in-people-at-higher-risk
Baby Formula Recall as Warning Issued Over Possible Bacteria Contamination: Produced in Michigan, the recalled formula is a powder given to infants with ...
newsweek.com/baby-formula-recall-warning-issued-over-possible-bacteria-contamination-1856822
How a new medication to treat psoriatic arthritis can help children: A new medication called abatacept is now available to treat psoriatic arthritis in children ...
medicalnewstoday.com/articles/how-a-new-medication-to-treat-psoriatic-arthritis-can-help-children
Asthma Drug Still Being Prescribed to Kids Despite Potential Mental Health Risks: The allergy and asthma drug montelukast, also known as Singulair ...
scientificamerican.com/article/asthma-drug-still-being-prescribed-to-kids-despite-potential-mental-health-risks/
Merck accused of downplaying early evidence of drug’s brain impact: An early magazine advertisement for Merck’s breakthrough asthma and allergy medicine ...
reuters.com/business/healthcare-pharmaceuticals/merck-accused-downplaying-early-evidence-drugs-brain-impact-2023-06-26/
FDA rejects first nasal spray alternative to epinephrine autoinjectors: The FDA rejected an alternative to epinephrine autoinjectors such as EpiPens ...
usatoday.com/story/news/health/2023/09/20/fda-rejects-first-nasal-spray-epipen-alternative/70907617007/
How an asthma medication may help treatment of children with food allergies: Study
goodmorningamerica.com/food/story/asthma-medication-treatment-children-food-allergies-study-105947603
Eosinophilic esophagitis: How the drug Dupixent has improved treatment: Experts say the approval of Dupixent to treat eosinophilic esophagitis has made treatment ...
medicalnewstoday.com/articles/eosinophilic-esophagitis-how-the-drug-dupixent-has-improved-treatment
The FDA put ‘Urgent’ on this Thanksgiving week turkey gravy recall. But, remain calm
star-telegram.com/news/recalls/article282241963.html
Gut microbes may determine patients' response to a drug that delays onset of type 1 diabetes
medicalxpress.com/news/2023-12-gut-microbes-patients-response-drug.html
Kimchi Jars Recalled Over Urgent Allergen Warning: A company in California recalled its kimchi after it mislabeled the product as not containing fish.
newsweek.com/kimchi-jars-recall-fda-urgent-allergen-warning-1855685
It’s stuffy nose season. Here’s how to cope: The popular nasal decongestant phenylephrine was deemed ineffective in pill form in September.
popsci.com/health/nasal-congestion-season/
Fudge Recall as Dire Warning Issued Over Products: A range of fudge products have been withdrawn from sale following the discovery of a major allergen.
newsweek.com/fudge-recall-egg-allergen-fda-warning-1852730
Roche settles US patent lawsuit against Biogen over blockbuster arthritis drug: Swiss pharmaceutical company Roche (ROG.S) has settled a patent lawsuit against U ...
reuters.com/business/healthcare-pharmaceuticals/roche-settles-us-patent-lawsuit-against-biogen-over-blockbuster-arthritis-drug-2023-10-23/
A Decongestant in Cold Medicines Is Ineffective. Here’s What to Use Instead.: Here’s what you can use instead.
nytimes.com/2023/09/12/well/live/decongestant-phenylephrine-cold-medicine-alternative.html
CVS pulls popular allergy and cold medicines because they don't work: Despite accounting for $1.8 billion in annual sales, an FDA panel said medicine containing ...
insider.com/cvs-pulls-phenylephrine-popular-allergy-cold-medicine-they-dont-work-2023-10
Novartis drug candidate scores interim win in rare kidney disease trial: Novartis (NOVN.S) said its experimental drug atrasentan was shown to have a positive ...
reuters.com/business/healthcare-pharmaceuticals/novartis-says-drug-candidate-is-successful-rare-kidney-disease-trial-2023-10-30/
Lilly's bowel disease drug gets US FDA nod for treatment in adults: Eli Lilly and Co (LLY.N) said on Thursday that the U.S. health regulator had approved its ...
reuters.com/business/healthcare-pharmaceuticals/eli-lillys-bowel-disease-drug-gets-us-fdas-approval-adults-2023-10-26/
FDA approves Omvoh, a first-of-its-kind treatment for ulcerative colitis: The FDA recently approved a new medication by Eli Lilly, mirikizumab ...
medicalnewstoday.com/articles/fda-approves-new-ulcerative-colitis-treatment-omvoh-eli-lilly
U.S. FDA approves Amgen's biosimilar version of J&J's psoriasis drug: The U.S. Food and Drug Administration on Tuesday approved Amgen's (AMGN ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-amgens-biosimilar-vesrion-jjs-stelara-2023-10-31/
Biotech Stock Continues Its Win Streak As Sales Nearly Triple: Argenx put up another strong quarter for immunology drug Vyvgart on Tuesday ...
investors.com/news/technology/biotech-stock-argenx-earnings-q3-2023/
A Decongestant in Cold Medicines Is Ineffective. Here’s What to Use Instead.: Here’s what you can use instead.
nytimes.com/2023/09/12/well/live/decongestant-phenylephrine-cold-medicine-alternative.html
Quick Glance: FDA advisers say popular nasal decongestant doesn't relieve congestion
- Advisers to the Food and Drug Administration say that the ingredient phenylephrine found in popular versions of Sudafed, Dayquil, and other medications does not relieve nasal congestion.
- The FDA assembled its external advisers to reevaluate phenylephrine as it became the main ingredient in over-the-counter decongestants after medicines with an older ingredient, pseudoephedrine, were moved behind pharmacy counters.
- If the FDA follows the panel's recommendations, Johnson & Johnson, Bayer, and other drugmakers may have to remove their oral medications containing phenylephrine from store shelves.
- This would likely result in consumers switching to behind-the-counter pseudoephedrine products or phenylephrine-based nasal sprays and drops.
FDA Rejects Nasal Spray For Severe Allergic Reactions—Delaying First Needle-Free EpiPen Alternative
forbes.com/sites/roberthart/2023/09/20/fda-rejects-nasal-spray-for-severe-allergic-reactions-delaying-first-needle-free-epipen-alternative/
UCB Gets FDA Nod for Psoriasis Drug With Warning on Risks: UCB SA won Food and Drug Administration approval for its psoriasis drug, although risks flagged by the ...
bloomberg.com/news/articles/2023-10-18/ucb-gets-us-fda-approval-for-psoriasis-drug-in-boost-for-sales
Boehringer launches 81% discounted biosimilar of AbbVie's Humira: Germany's Boehringer Ingelheim on Monday launched an unbranded version of its biosimilar of ...
reuters.com/business/healthcare-pharmaceuticals/boehringer-launches-unbranded-humira-biosimilar-81-discount-2023-10-02/
Allergy-treating nasal spray needs more research before approval: U.S. FDA: The ARS product is one of several needle-free devices being developed to treat ...
globalnews.ca/news/9975116/fda-allergic-reactions-nasal-spray/
US FDA approves NDA for Sun Pharma's alopecia drug Deuruxolitinib: Sun Pharma's NDA submission comprised data from two Phase-III trials, 'THRIVE-AA1' and ...
business-standard.com/companies/news/us-fda-approves-nda-for-sun-pharma-s-alopecia-drug-deuruxolitinib-123100600704_1.html
FDA says it needs more research before deciding to approve nasal spray to treat dangerous allergies
ctvnews.ca/health/fda-says-it-needs-more-research-before-deciding-to-approve-nasal-spray-to-treat-dangerous-allergies-1.6571892
Baltimore company designing rheumatoid arthritis drug gets OK from FDA to start testing on patients
baltimoresun.com/health/bs-hs-rheumatoid-arthritis-mymd-20231002-gjjglysiezbi3lnokzaznmt4lq-story.html
FDA sends warning letters to CVS, Walgreens other companies over unapproved eye products
foxbusiness.com/lifestyle/fda-sends-warning-letters-cvs-walgreens-companies-over-unapproved-eye-products
Nestle Divests Peanut-Allergy Drug Palforzia to Stallergenes: Nestle SA sold its peanut-allergy medicine business to Swiss health-care group Stallergenes Greer ...
bloomberg.com/news/articles/2023-09-04/nestle-sells-peanut-allergy-business-to-stallergenes-greer
No, The OTC Antihistamine Benadryl Is Not Being Removed From U.S. Pharmacies: FDA advisory committee vote on ineffectiveness of phenylephrine as nasal ...
forbes.com/sites/joshuacohen/2023/09/13/the-otc-antihistamine-benadryl-is-not-being-removed-from-us-pharmacies/
FDA rejects first needle-free alternative to EpiPens, calling for additional research
nbcnews.com/health/health-news/fda-nasal-spray-epinephrine-neffy-rcna105078
FDA says popular decongestant for colds and allergies doesn't work: To get some relief, you might turn to medicine like Sudafed or DayQuil. But the FDA now says ...
newschannel5.com/news/fda-says-popular-decongestant-for-colds-and-allergies-doesnt-work
Popular nasal decongestant doesn't actually relieve congestion, FDA experts say: The leading decongestant used by millions of Americans looking for relief from a ...
omaha.com/life-entertainment/nation-world/wellness/nasal-decongestant-sudafed-allegra-dayquil/article_9e504679-5178-5557-8f92-6e3faf093dd1.html
Food allergies can be deadly but also costly for those concerned: The latest treatment for peanut allergy can cost around $10,000 a year and was supposed to be a ...
swissinfo.ch/eng/business/food-allergies-can-be-deadly-but-also-costly-for-those-concerned/48775396
A sesame allergy law has made it harder to avoid the seed. Here's why: Sesame is now the 9th official allergen. The FDA designation was supposed to protect ...
npr.org/sections/health-shots/2023/08/30/1196640997/a-sesame-allergy-law-has-made-it-harder-to-avoid-the-seed-heres-why
Editorial: FDA fumbles new regulations targeting sesame: The intention, of course, was to make it easier for those with a sesame allergy to avoid problems ...
bostonherald.com/2023/08/06/editorial-fda-fumbles-new-regulations-targeting-sesame/
Silicone Breast Implants Were Banned in the ’90s for Making Women Sick. How Did They Make a Comeback?
slate.com/technology/2022/06/breast-implant-illness-what-is-it-cause-treatment-science.html
Sesame is being newly added to some foods in the U.S. The FDA says it doesn't violate an allergy law
ctvnews.ca/business/sesame-is-being-newly-added-to-some-foods-in-the-u-s-the-fda-says-it-doesn-t-violate-an-allergy-law-1.6495813
A possibly ‘serious’ mistake caused a Tostitos salsa dip to be recalled nationwide
kentucky.com/news/recalls/article276516381.html
Roche sues Biogen over biosimilar of blockbuster arthritis drug: Roche (ROG.S) and two of its subsidiaries sued biotech company Biogen (BIIB ...
reuters.com/legal/litigation/roche-sues-biogen-over-biosimilar-blockbuster-arthritis-drug-2023-07-14/
Quick Glance: Roche Sues Biogen Over Biosimilar of Blockbuster Arthritis Drug
- Roche's billion-dollar drug treats both COVID-19 and rheumatoid arthritis.
- Roche claims Biogen's similar version would infringe patents.
For Alan Fletcher and many others, a new alopecia drug is life-changing: The Neighbours star lost his hair to alopecia areata, but thanks to drug used to treat ...
theage.com.au/lifestyle/health-and-wellness/for-alan-fletcher-and-many-others-a-new-alopecia-drug-is-life-changing-20230622-p5diix.html
2 BelVita Breakfast Sandwich varieties recalled for possible peanut contamination
freep.com/story/news/local/michigan/2023/07/05/belvita-breakfast-sandwich-recall-peanut-contamination/70383671007/
A new treatment is restoring skin coloration to some with vitiligo. It's giving patients hope.
usatoday.com/story/news/health/2022/10/20/vitiligo-treatment-ruxolitinib-opzelura-effective/10544448002/
Merck accused of downplaying early evidence of drug’s brain impact: An early magazine advertisement for Merck’s breakthrough asthma and allergy medicine ...
reuters.com/business/healthcare-pharmaceuticals/merck-accused-downplaying-early-evidence-drugs-brain-impact-2023-06-26/
Alopecia patients finally have an FDA-approved hair-loss treatment: The drug, Olumiant, is an oral medication that works by suppressing the autoimmune reaction ...
popsci.com/science/fda-approves-first-treatment-alopecia/
Chick peas, roasted nuts, spread recalled in Florida, Texas, California, 4 other states
miamiherald.com/news/recalls/article274526306.html
Here’s why three kinds of pretzels were recalled from Hy-Vee stores in 8 states: Hy-Vee pretzels in Honey Mustard, Dill Pickle, Salt and Vinegar varieties might ...
miamiherald.com/news/recalls/article274434845.html
Brownie brittle with a popular candy is recalled. It could cause serious allergy issues
charlotteobserver.com/news/recalls/article273586940.html
Costco Is Recalling Protein Bars — Here’s What You Need to Know: In an announcement made by the U.S. Food & Drug Administration (FDA), Costco is recalling a ...
thekitchn.com/costco-simplyprotein-bars-recall-april-2023-23521302
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics